Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Dutch who wrote (26703)	4/30/2007 7:55:11 PM
From: Paul Senior	Read Replies (2) \| Respond to of 78751

BSX. Oh yes. Definitely a stretch. I'll defer to your expertise and knowledge here, Dutch. Still, I'm going to try to hold on to my few BSX shares. The p/sales, p/book are at multi-year lows. Things are very bleak for the company. I'm hoping for a pony in the pile though. According to Yahoo, there are 28,000 employees at BSX and they are in several areas, not just the stents: "The company offers its products in three groups: Cardiovascular, Endosurgery, and Neuromodulation." (C'mon you new product development guys! Give us a blockbuster!) To me, the question isn't where the company is now, but where it will be in three years. I don't know, but I am betting in a better position than now. Not betting much though (-g-)